LabCorp To Acquire Genzyme Unit For $925M
Genzyme Corp. has sold its Genzyme Genetics division to Laboratory Corp. of America Holdings for $925 million in cash, a move that Genzyme said would allow it to focus on core...To view the full article, register now.
Already a subscriber? Click here to view full article